OPKO Health Total Liabilities 2010-2023 | OPK

OPKO Health total liabilities from 2010 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.857B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.398B 26.71
Intuitive Surgical (ISRG) United States $133.018B 80.13
DexCom (DXCM) United States $54.600B 91.31
Edwards Lifesciences (EW) United States $53.337B 35.30
IQVIA Holdings (IQV) United States $43.712B 25.92
IDEXX Laboratories (IDXX) United States $41.050B 49.08
Alcon (ALC) Switzerland $39.236B 28.93
STERIS (STE) Ireland $20.039B 23.72
Waters (WAT) United States $18.401B 26.40
Hologic (HOLX) United States $18.006B 19.87
SONOVA HOLDING (SONVY) Switzerland $16.668B 0.00
ShockWave Medical (SWAV) United States $12.299B 84.98
Fresenius Medical Care AG KGaA (FMS) Germany $12.183B 15.04
Sysmex ADR (SSMXY) Japan $10.136B 31.79
Teleflex (TFX) United States $9.946B 15.62
Penumbra (PEN) United States $7.979B 98.64
Masimo (MASI) United States $7.192B 40.33
Globus Medical (GMED) United States $6.964B 22.08
Glaukos (GKOS) United States $5.066B 0.00
Integer Holdings (ITGR) United States $4.130B 26.40
LivaNova (LIVN) United Kingdom $3.018B 19.91
TransMedics (TMDX) United States $2.908B 0.00
PROCEPT BioRobotics (PRCT) United States $2.697B 0.00
Elekta AB (EKTAY) Sweden $2.654B 18.21
Nihon Kohden (NHNKY) Japan $2.411B 20.40
Integra LifeSciences Holdings (IART) United States $2.309B 9.48
Tandem Diabetes Care (TNDM) United States $2.267B 0.00
Inari Medical (NARI) United States $2.213B 381.80
RxSight (RXST) United States $1.954B 0.00
Alphatec Holdings (ATEC) United States $1.758B 0.00
Veracyte (VCYT) United States $1.494B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.864B 15.99
Artivion (AORT) United States $0.862B 99.62
Paragon 28 (FNA) United States $0.799B 0.00
OrthoPediatrics (KIDS) United States $0.742B 0.00
Silk Road Medical (SILK) United States $0.688B 0.00
Treace Medical Concepts (TMCI) United States $0.659B 0.00
SiBone (SIBN) United States $0.619B 0.00
Mesa Laboratories (MLAB) United States $0.564B 19.13
IRadimed (IRMD) United States $0.537B 31.21
ORTHOFIX MEDICAL INC (OFIX) United States $0.507B 0.00
Nevro (NVRO) United States $0.459B 0.00
NeuroPace (NPCE) United States $0.389B 0.00
Pulse Biosciences (PLSE) United States $0.379B 0.00
Pacific Biosciences Of California (PACB) United States $0.364B 0.00
Tactile Systems Technology (TCMD) United States $0.357B 12.03
CVRx (CVRX) United States $0.311B 0.00
AxoGen (AXGN) United States $0.300B 0.00
Sight Sciences (SGHT) United States $0.278B 0.00
EDAP TMS S.A (EDAP) France $0.254B 0.00
AngioDynamics (ANGO) United States $0.235B 0.00
Accuray (ARAY) United States $0.218B 0.00
Atossa Genetics (ATOS) United States $0.188B 0.00
Semler Scientific (SMLR) United States $0.187B 10.08
908 Devices (MASS) United States $0.185B 0.00
Alpha Tau Medical (DRTS) Israel $0.173B 0.00
Inogen (INGN) United States $0.166B 0.00
ClearPoint Neuro (CLPT) United States $0.144B 0.00
Delcath Systems (DCTH) United States $0.139B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
KORU Medical Systems (KRMD) United States $0.101B 0.00
Envoy Medical (COCH) United States $0.098B 0.00
Spectral Diagnostics (EDTXF) Canada $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.074B 0.00
EnVVeno Medical (NVNO) United States $0.070B 0.00
SEP Acquisition (SEPA) United States $0.059B 0.00
Autonomix Medical (AMIX) United States $0.059B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Sensus Healthcare (SRTS) United States $0.054B 109.33
Vasomedical (VASO) United States $0.050B 9.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
DarioHealth (DRIO) United States $0.045B 0.00
InspireMD (NSPR) Israel $0.043B 0.00
Aspira Women's Health (AWH) United States $0.042B 0.00
ReWalk Robotics (LFWD) Israel $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
LENSAR (LNSR) United States $0.037B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Lucid Diagnostics (LUCD) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.032B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.021B 0.00
Accelerate Diagnostics (AXDX) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.015B 0.00
Biosig Technologies (BSGM) United States $0.015B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Microbot Medical (MBOT) United States $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00